Role of hemochromatosis C282Y and H63D mutations in HFE gene in development of type 2 diabetes and diabetic nephropathy

Diabetes Care

Volumn 24, Issue 7, 2001, Pages 1187-1191

  Moczulski, Dariusz K ^a   Grzeszczak, Wladyslaw ^a,b   Gawlik, Barbara ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

^b Dept of Int Medicine and Diabetes ^*  (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; HFE PROTEIN, HUMAN; HLA ANTIGEN; HLA ANTIGEN CLASS 1; MEMBRANE PROTEIN;

ALBUMINURIA; AMINO ACID SUBSTITUTION; ARTICLE; BODY MASS; DIABETIC NEPHROPATHY; FEMALE; GENETIC POLYMORPHISM; GENETICS; HEMOCHROMATOSIS; HETEROZYGOTE; HUMAN; HYPERTENSION; IMMUNOLOGY; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; ONSET AGE; POINT MUTATION;

AGE OF ONSET; ALBUMINURIA; AMINO ACID SUBSTITUTION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; HEMOCHROMATOSIS; HEMOGLOBIN A, GLYCOSYLATED; HETEROZYGOTE; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; HYPERTENSION; MALE; MEMBRANE PROTEINS; MIDDLE AGED; POINT MUTATION; POLYMORPHISM, GENETIC;

EID: 0035403064     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.24.7.1187     Document Type: Article

References (18)

1. Feder JN, Gnirke A, Thomas W, Tsuchihashi Z, Ruddy DA, Basava A, Dormishian F, Domingo R Jr, Ellis MC, Fullan A, Hinton LM, Jones NL, Kimmel BE, Kronmal GS, Lauer P, Lee VK, Loeb DB, Mapa FA, McClelland E, Meyer NC, Mintier GA, Moeller N, Moore T, Morikang E, Wolff RK: A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 13:399-408, 1996
2. Niederau C, Fischer R, Sonnenberg A, Stremmel W, Trmpisch HJ, Strohmeyer G: Survival and causes of death in cirrhotic and noncirrhotic patients with primary hemochromatosis. N Engl J Med 313:1256-1262, 1985
3. Adams PC, Speechley M, Kertesz AE: Long-term survival analysis in hereditary hemochromatosis. Gastroenterology 101:368-372, 1991
4. Fargion S, Mandelli C, Piperno A, Cesana B, Fracanzani AL, Fraquelli M, Bianchi PA, Fiorelli G, Conte D: Survival and prognostic factors in 212 Italian patients with genetic hemochromatosis. Hepatology 15:655-659, 1992
5. Niederau C, Fisher R, Purschel A, Stremmel W, Haussinger D, Strohmeyer G: Long-term survival in patients with hereditary hemochromatosis. Gastroenterology 110:1107-1119, 1996
6. Nelson RL, Davis FG, Persky V, Becker E: Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis. Cancer 76:875-879, 1995
7. Bulaj ZJ, Griffen LM, Jorde LB, Edwards CQ, Kushner JP: Clinical and biochemical abnormalities in people heterozygous for hemochromatosis. N Engl J Med 335:1799-1805, 1996
8. Tuomainen TP, Nyyssönen K, Salonen R, Tervahauta A, Korpela H, Lakka T, Kaplan GA, Salonen JT: Body iron stores are associated with serum insulin and blood glucose concentrations: population study in 1,013 eastern Finnish men. Diabetes Care 20:426-428, 1997
9. Kwan T, Leber B, Ahuja S, Carter R, Gerstein H: Patients with type 2 diabetes have a high frequency of the C282Y mutation of the hemochromatosis gene. Clin Invest Med 21:251-257, 1998
10. Fernandes-Real JM, Vendrell J, Baiget M, Gimferrer E, Ricart W: C282Y and H63D mutations of the hemochromatosis candidate gene in type 2 diabetes (Letter). Diabetes Care 22:525-526, 1999
11. Frayling T, Ellard S, Grove J, Walker M, Hattersley AT: C282Y mutation in HFE (haemochromatosis) gene and type 2 diabetes (Letter). Lancet 351:1933-1934, 1998
12. Braun J, Donner H, Plock K, Rau H, Usadel KH, Badenhoop K: Hereditary haemochromatosis mutations (HFE) in patients with type 2 diabetes mellitus. Diabetologia 41:983-984, 1998
13. Florkowski CM, George PM, Willis JA, Stott MK, Burt MJ, Upton JD, Nesbit J, Walmsley TA, Scott RS: Haemochromatosis gene mutations Cys282Tyr and His63Asp are not increased in Type 2 diabetic patients compared with the Canterbury (New Zealand) general population. Diabetes Res Clin Pract 43:199-203, 1999
14. Dubois-Laforgue D, Caillat-Zucman S, Djilali-Saiah I, Larger E, Mercadier A, Boitard C, Bach JF, Timsit J: Mutations in HFE, the hemochromatosis candidate gene, in patients with NIDDM (Letter). Diabetes Care 21:1371-1372, 1998
15. Nankivell BJ, Tay YC, Boadle RA, Harris DC: Lysosomal iron accumulation in diabetic nephropathy. Ren Fail 16:367-381, 1994
16. Loebstein R, Lehotay DC, Luo X, Bartfay W, Tyler B, Sher GD: Diabetic nephropathy in hypertransfused patients with beta;-thalassemia: the role of oxidative stress. Diabetes Care 21:1306-1309, 1998
17. National Diabetes Data Group: Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance. Diabetes 28:1039-1047, 1979
18. Warram JH, Gearin G, Laffel L, Krolewski AS: Effect of duration of type I diabetes on prevalence of stages of diabetic nephropathy defined by urinary albumin/creatinine ratio. J Am Soc Nephrol 7:930-937, 1996